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Immunoreactive trypsin is one of several exocrine pancreatic proteins whose concentrations in the blood of infants with CF are increased (3, 7) . These high concentrations may be due to an increased backflow of enzymes caused by partial obstruction of the pancreatic ducts. IRT activity is also decreased in dried fecal specimens obtained from CF neonates (6, 9) . Trypsin is found in amniotic fluid as early as the 12th gestational week and in meconium in the 16th (14) . IRT exists in two biologically significant forms, free trypsinogen and trypsin in complex with alAT (1, 2, 5). These forms are found in serum and other body fluids containing protease inhibitors. An increased blood concentration of IRT in CF fetuses would theoretically lead to an increased urinary excretion of trypsinogen to the amniotic fluid. A decreased trypsin content of CF meconium would theoretically lead to a decreased trypsin-aIAT complex concentration in amniotic fluid. Thus, assuming the CF fetal pancreatic glands to be affected in early intra-uterine life, as seems to be the case here in three of four cases, prenatal analysis and characterization of IRT from the amniotic fluid of normal and CF fetuses might provide useful diagnostic data.
Accordingly, the purpose of the present study was to determine and characterize IRT of amniotic fluid obtained at preterm deliveries and from normal and CF fetuses in the 16th-20th gestational week.
MATERIALS AND METHODS
Thirty-nine samples of amniotic fluid were obtained by amniocentesis between the 16th and 20th g.w. (determined by ultrasonic scanning); 32 of the samples were from pregnancies where there was increased risk of chromosome abnormality or neural tube defect, but of which the outcome was normal. Of seven pregnancies, where samples were taken because the mothers had already had children with CF, three had normal outcomes (referred to as CF controls in the text), whereas four resulted in infants with cystic fibrosis. Nine samples were from preterm pregnancies, 32-36 g.w. All samples were stored at -20°C until analyzed (the 7 CF risk samples for 0.5-2 years, the remainder 1-4 months).
IRT was determined in duplicates with a conventional RIA (1). The normal IRT level in healthy individuals determined by this RIA is 25 pg/liter. The IRT-cxIAT complex was determined after gel filtration of the samples with a double antibody solid phase RIA (5). This RIA measures only IRT in complex with alAT (Fig. 2) . The conventional assay, however, also measures trypsinogen and free trypsin. Furthermore, the presence of free aIAT does not affect results when measuring IRT in complex with alAT.
The aIAT concentration was analyzed by electroimmunoassay ( I I). Antigen-antibody crossed immunoelectrophoresis was performed as previously described (13) . Gel filtration of amniotic fluid was done on an AcA 54 column, 0.9 x 16 cm (obtained from LKB, Bromma, Sweden).
RESULTS
In midtrimester (16-20 g.w.), the mean f SD IRT concentration in amniotic fluid from normal pregnancies was 28 f 25 pg/ liter (range, 3-100 pgpiter; n = 35). The IRT concentration of preterm amniotic fluid (32-36 g.w.) was 1 1 f 14 pgpiter (range, 1-1 8 pglliter; n = 9). Figure 1 shows the respective IRT concentrations.
The IRT was separated into two peaks by gel filtration; the first peak reacted and was measured by the specific trypsin-alAT assay; the second corresponded to the molecular weight of tryp sinogen and was measured by the IRT assay (Fig. 2) . The midpregnancy samples contained trypsin in complex with aIAT in a concentration of 66 f 56 pgbiter (range, 30-200 pgbiter; n = 13), and small amounts of trypsinogen, 16 f 15 pg/liter (range, 0-50 pglliter; n = 13). However, no trypsinogen was found in preterm samples, in which all the IRT was composed of the trypsin-alAT complex, 22 It 37 jigbiter (range, 0-89 pgbiter; n = 6) (Fig. 3) . The amniotic fluid samples from three of four CF fetuses had very low concentrations of IRT (Fig. 1) . Both trypsinogen and trypsin in complex with alAT were found after gel filtration, although concentrations, particularly that of trypsin in complex with alAT, were low (Fig. 3) .
T o t a l irT
The alAT concentration in amniotic fluid was 140 f 110 mg/ liter (range, 25-230 mg/liter; n = 39). Crossed immunoelectrophoresis with antibodies specific for alAT gave only one immunoreactive peak, which is consistent with free aIAT. When active bovine trypsin was added to the samples before the crossed immunoelectrophoresis, a peak appeared whose anionic migration rate was slower than that of free alAT, thus confirming that the bulk of the amniotic fluid aIAT was free and active. from CF fetuses (0) and CF control fetuses m.
DISCUSSION
The IRT concentration of amniotic fluid found here is onetenth ofthat reported in a recent investigation (14) , a discrepancy due to differences in purity of standard preparations. The method used in the report referred to gives a mean value in serum of healthy subjects which is I0 times that determined by our method (1, 8) . Pocknee and Abramovich (14) suggested that the pancreatic enzymes reach the amniotic fluid via a physiological transfer of meconium in midpregnancy (D. R. Abramovich and E. S. Gray, unpublished ), a hypothesis confirmed by our gel filtration results which showed that the bulk of IRT in amniotic fluid consists of the trypsin-alAT complex. The active meconium trypsin is inactivated by aIAT which is available in large amounts in amniotic fluid. The discrepancy found between the results obtained by the RIA for total IRT, and those of the double antibody RIA for the trypsin-a,AT complex, is explained by the fact that trypsin loses about 75% of its immunoreactivity after forming a complex with alAT (2) . Accordingly, the trypsin-alAT RIA is preferable when the predominant form of IRT is trypsinaIAT complexes as in amniotic fluid.
The wide variation of trypsin-alAT concentrations in normal amniotic fluid may be explained by an intermittent meconium passage, and wide variation of the amniotic fluid volume in the 17-18 g.w. (1 2) . No free trypsin, or trypsin-a,AT, passes from the mother to the amniotic fluid, since these complexes are never present in the normal circulation (1, 5) . Three of four CF fetuses had very low trypsin-alAT concentrations in amniotic fluid. This fact may indicate a decreased trypsin meconium content in these CF fetuses.
Trypsinogen may be derived from both maternal and fetal sources. The ratio between amniotic fluid and maternal serum concentrations of proteins with a molecular weight slightly greater than that of trypsinogen (25,000 daltons), is quite variable, roughly 0.03-0.25 (10) . We found low concentrations of trypsinogen in preterm amniotic fluid, indicating a minor maternal contribution of trypsinogen. Accordingly, the amniotic fluid trypsinogen should mainly be of fetal origin and an increased concentration of trypsinogen in CF gestations was theoretically likely. Trypsinogen concentrations, however, were low even in CF amniotic fluids. Thus, other unknown factors probably influence the trypsinogen excretion in the amniotic fluid.
IRT is considered to be stable in serum samples stored at -20°C even for several years (4) . The effect of storage upon the IRT concentration of amniotic fluid has not yet been studied.
The fact, that three of four amniotic fluid IRT concentrations from CF fetuses were <I0 pglliter, compared with about one of four from normal pregnancies, suggests that the pancreas may be affected in midterm fetuses with CF. Further studies are necessary to determine the value of IRT analysis in the prenatal diagnosis of CF.
